...
首页> 外文期刊>Neurogastroenterology and motility >Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs.
【24h】

Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs.

机译:犬尿酸在实验性结肠梗阻过程中会抑制肠道过度运动和黄嘌呤氧化酶活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Kynurenic acid (KynA), an endogenous antagonist of N-methyl-d-aspartate (NMDA) glutamate receptors, protects the central nervous system in excitotoxic neurological diseases. We hypothesized that the inhibition of enteric glutamate receptors by KynA may influence dysmotility in the gastrointestinal tract. Group 1 of healthy dogs served as the sham-operated control, in group 2, the animals were treated with KynA, while in groups 3 and 4 mechanical colon obstruction was maintained for 7 h. Group 4 was treated with KynA at the onset of ileus. Hemodynamics and motility changes were monitored, and the activities of xanthine oxidoreductase (XOR) and myeloperoxidase (MPO) were determined from tissue samples. Colon obstruction induced a hyperdynamic circulatory reaction, significantly elevated the motility index and increased the mucosal leucocyte accumulation and the XOR activity. The KynA treatment augmented the tone of the colon, permanently decreased the motility index of the giant colonic contractions and reduced the increases in XOR and MPO activities. These effects were concomitant with the in vitroinhibition of XOR activity. In conclusion, KynA antagonizes the obstruction-induced motility responses and XOR activation in the colon. Inhibition of enteric NMDA receptors may provide an option to influence intestinal hypermotility and inflammatory changes.
机译:尿酸(KynA)是N-甲基-d-天冬氨酸(NMDA)谷氨酸受体的内源性拮抗剂,在兴奋性毒性神经系统疾病中保护中枢神经系统。我们假设KynA对肠谷氨酸受体的抑制作用可能会影响胃肠道的运动障碍。将健康狗的第1组用作假手术对照,在第2组中,将动物用KynA治疗,而在第3和第4组中,将机械性肠梗阻维持7小时。第4组在肠梗阻发作时用KynA治疗。监测血流动力学和运动力变化,并从组织样品中测定黄嘌呤氧化还原酶(XOR)和髓过氧化物酶(MPO)的活性。结肠梗阻引起高动力循环反应,显着提高运动指数并增加粘膜白细胞积累和XOR活性。 KynA处理可增强结肠的张力,永久性降低巨大结肠收缩的运动指数,并减少XOR和MPO活性的增加。这些作用与XOR活性的体外抑制同时发生。总之,KynA拮抗肠梗阻引起的运动反应和XOR激活。肠内NMDA受体的抑制作用可能为影响肠蠕动和炎症变化提供一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号